Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3Phase EARLY_PHASE1 1Phase 4 1Phase 1/2 1Phase 1 1

Status

Completed 18Terminated 7Unknown 3Not yet recruiting 2Withdrawn 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 1Genitourinary 1Endocrine 1

Conditions

Thyroid Cancer Metastatic 1Osteoblastoma 1Kidney Neoplasms 1Granuloma, Giant Cell 1Chondroblastoma 1Carcinoma, Renal Cell 1Bone Cysts, Aneurysmal 1

Interventions

Cisplatin 267Oxaliplatin 194Carboplatin 189Capecitabine 183Docetaxel 176apatinib 164Paclitaxel 158Bevacizumab 155Gemcitabine 154Radiotherapy 146camrelizumab 145Fluorouracil 144Cyclophosphamide 123Irinotecan 119Drug Therapy 118sintilimab 107Etoposide 99anlotinib 90S 1 (combination) 88Leucovorin 85pembrolizumab 82Pemetrexed 78Doxorubicin 77toripalimab 76tislelizumab 75Dexamethasone 70Trastuzumab 65Neoadjuvant Therapy 64Rituximab 62Cetuximab 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Denosumab × Clear all
NCT03280667 2023-03-29

KEYPAD

Australian and New Zealand Urogenital and Prostate Cancer Trials Group

Phase 2 Unknown
59 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT03732495 2022-03-29

LENVOS

Centre Leon Berard

Phase 2 Unknown
35 enrolled
EndocrineHead & Neck

Thyroid Cancer Metastatic

NCT03605199 2019-08-26

Denosumab in Subjects With Giant Cell Rich Tumors of Bone

Leiden University Medical Center

Phase 2 Unknown
60 enrolled

Chondroblastoma, Granuloma, Giant Cell, Bone Cysts, Aneurysmal, Osteoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡